Breaking News Instant updates and real-time market news.

ZAYO

Zayo Group

$32.74

0.04 (0.12%)

, GTT

GTT Communications

$31.80

-0.15 (-0.47%)

04:55
08/08/17
08/08
04:55
08/08/17
04:55

Cowen to hold a summit

3rd Annual Communications Infrastructure Summit is being held in Boulder, Colorado on August 7-8.

ZAYO

Zayo Group

$32.74

0.04 (0.12%)

GTT

GTT Communications

$31.80

-0.15 (-0.47%)

EQIX

Equinix

$444.23

-1.35 (-0.30%)

CONE

CyrusOne

$57.98

-0.61 (-1.04%)

CTL

CenturyLink

$22.34

-0.13 (-0.58%)

CCOI

Cogent

$43.20

-0.65 (-1.48%)

COR

CoreSite Realty

$107.95

-0.07 (-0.06%)

  • 08

    Aug

  • 08

    Aug

  • 21

    Aug

ZAYO Zayo Group
$32.74

0.04 (0.12%)

07/17/17
WELS
07/17/17
NO CHANGE
WELS
Outperform
Wells says Crown Castle $7B deal would provide attractive comp for Zayo
Wells Fargo analyst Jennifer Fritzsche noted the Reuters report that claims Crown Castle (CCI) has bid in the $7B range for Lightower Fiber Networks. She added the news is not surprising to her given how aggressive Crown Castle has been in building its fiber portfolio, which is a strategy with which she agrees. She believes such an acquisition would provide an attractive comp for Zayo Group (ZAYO), as she noted that Lightower is growing top line at a much faster rate but Zayo covers triple the geography. Fritzsche keeps Outperform ratings on Crown Castle and Zayo Group.
06/22/17
KEYB
06/22/17
NO CHANGE
KEYB
Zayo Group may not become takeover target, says KeyBanc
KeyBanc analyst Brandon Nispel sees a number of reasons why Zayo may not become a takeover target, even though rumors about such a deal are circulating. Among the reasons are his belief that "more fiber will be built due to changing network architecture and his belief that "a number of smaller providers in the market could fill a fiber need in a less expensive manner." He expects the company's fundametnals to continue to disappoint the market and keeps a Sector Weight rating on the shares.
05/19/17
GSCO
05/19/17
DOWNGRADE
Target $39
GSCO
Buy
Zayo Group downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman analyst Brett Feldman removed Zayo Group from the Conviction Buy List following Q1 results that indicate a near-term acceleration in revenue growth will take time to materialize. The analyst said bookings and growth missed expectations and said a near-term reaccelerating is unlikely. Longer-term, Feldman continues to see a ramp in OTT video offerings, reintroduction of unlimited data plans by wireless carriers, and continued cloud adoption as growth drivers. The analyst rates Zayo Group a Buy with a $39 price target.
05/10/17
05/10/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Yelp (YELP) downgraded to Neutral from Buy at MKM Partners and to Sector Perform from Outperform at RBC Capital. 2. General Dynamics (GD) downgraded to Market Perform from Outperform at Bernstein with analyst Douglas Harned downgraded the stock based on valuation. 3. Zayo Group (ZAYO) downgraded to Market Perform from Strong Buy at Raymond James and to Neutral from Overweight at JPMorgan. 4. U.S. Steel (X) downgraded to Market Perform from Outperform at Cowen with analyst Novid Rassouli citing lack of earnings visibility. 5. Rocket Fuel (FUEL) downgraded to Neutral from Outperform at Credit Suisse with analyst Stephen Ju citing "sloppy first quarter results." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GTT GTT Communications
$31.80

-0.15 (-0.47%)

03/09/17
CHLM
03/09/17
NO CHANGE
Target $40
CHLM
Buy
GTT Communications pullback creates 'attractive entry point,' says Craig-Hallum
Craig-Hallum analyst George Sutton says that while Hibernia's revenues declined in Q4 and will likely weigh on GTT Communications' organic growth targets for the next quarter or two, this was baked in. Further, the analyst notes that Hibernia acquisition represents "a giant leap" toward achieving the company's financial targets of $1B in revenue and $250M in adjusted EBITDA. Sutton views GTT Communications as a well-run organization, and says the pullback in the shares creates an "attractive entry point." He reiterates a Buy rating and $40 price target on the stock.
05/05/17
OPCO
05/05/17
NO CHANGE
Target $35
OPCO
Outperform
GTT Communications price target raised to $35 from $30 at Oppenheimer
Oppenheimer analyst Timothy Horan raised his price target for GTT Communications to $35 from $30 based on 2018 estimates as he believes the company will be successful in accelerating growth in 2018. The analyst reiterates an Outperform rating on the shares.
05/05/17
COWN
05/05/17
NO CHANGE
Target $40
COWN
Outperform
GTT Communications remains significantly undervalued, says Cowen
Cowen analyst Jonathan Charbonneau noted GTT Communications reported solid Q1 results including revenue and EBITDA ahead of expectations. He believes the results show the company is executing well on its strategy and is significantly undervalued. Charbonneau reiterated his Outperform rating and raised his price target to $40 from $36 on GTT Communications shares.
03/10/17
OPCO
03/10/17
NO CHANGE
OPCO
CenturyLink, GTT Communications offer buying opportunities, says Oppenheimer
Oppenheimer analyst Timothy Horan sees an opportunity in CenturyLink (CTL), GTT Communications (GTT) and Boingo Wireless (WIFI) post earnings given what he views as "fundamental dislocations" in stock prices. For CenturyLink, the analyst remains confident in the Level 3 (LVLT) closing and in the sustainability of the dividend afterwards. Horan continues to be a buyer of these names on weakness.
EQIX Equinix
$444.23

-1.35 (-0.30%)

05/02/17
OPCO
05/02/17
NO CHANGE
Target $472
OPCO
Outperform
Equinix price target raised to $472 from $440 at Oppenheimer
Oppenheimer analyst Timothy Horan raised his price target for Equinix (EQIX) to $472 from $440 after the company closed its acquisition of Verizon's (VZ) 29 data centers. The analyst sees upside from continued strong neutral datacenter demand with Verizon adding to Equinix's densely connected footprint, but also expanding its enterprise channel. He reiterates an Outperform rating on Equinix's shares.
05/11/17
ADAM
05/11/17
NO CHANGE
Target $525
ADAM
Buy
Equinix price target raised to $525 from $465 at Canaccord
Canaccord analyst Paul Morgan raised his price target on Equinix to $525 from $465 following meetings with management. The analyst said he sees near-term upside from the portfolio's top asset, selling into 600 new customer logos, and absorbing capacity from other locations. Morgan sees Equinix as well positioned to deliver double digit secular growth and he reiterated his Buy rating on the shares.
06/30/17
FBCO
06/30/17
INITIATION
Target $510
FBCO
Outperform
Equinix initiated with an Outperform at Credit Suisse
Credit Suisse analyst Sami Badri started coverage of the Data Center REITS, initiating Equinix with an Outperform rating and $510 price target, contending that the company has a "wide lead" on interconnection peering points and customer interconnection services and that it is leading the "colocation boom."
05/25/17
NOMU
05/25/17
INITIATION
Target $490
NOMU
Buy
Equinix initiated with a Buy at Nomura Instinet
Nomura initiated Jeffrey Kvaal initiated Equinix with a Buy and a $490 price target saying its scale positioned it well for the cloud migration, which the firm's networking coverage suggests is accelerating. The analyst's estimates are above consensus as each new connection raises the value of Equinix's connectivity.
CONE CyrusOne
$57.98

-0.61 (-1.04%)

06/30/17
FBCO
06/30/17
INITIATION
Target $73
FBCO
Outperform
CyrusOne initiated with an Outperform at Credit Suisse
Credit Suisse analyst Sami Badri started coverage of the Data Center REITS, initiating CyrusOne with an Outperform rating and $73 price target, calling it his highest conviction call in the sector. He believes the multi-tenant data center market is in its early innings and he sees strong execution from CyrusOne's growing enterprise oriented salesforce, he tells investors.
04/06/17
MACQ
04/06/17
INITIATION
Target $58
MACQ
Outperform
CyrusOne initiated with an Outperform at Macquarie
Macquarie initiated CyrusOne with an Outperform and a $58 price target.
04/25/17
MUFG
04/25/17
INITIATION
Target $54
MUFG
Neutral
CyrusOne initiated with a Neutral at MUFG
MUFG analyst Stephen Bersey started CyrusOne with a Neutral rating and $54 price target.
06/12/17
LEHM
06/12/17
NO CHANGE
Target $64
LEHM
Overweight
CyrusOne price target raised to $64 from $58 at Barclays
Barclays analyst Amir Rozwadowski raised his price target for CyrusOne shares to $64 citing a continued positive view on tower fundamentals despite the year-to-date stock rallies. CyrusOne remains the analyst's preferred sector pick. He keeps an Overweight rating on the shares.
CTL CenturyLink
$22.34

-0.13 (-0.58%)

06/19/17
MSCO
06/19/17
NO CHANGE
Target $27
MSCO
Overweight
CenturyLink whistleblower suit impact likely limited, says Morgan Stanley
Morgan Stanley analyst Simon Flannery said there could be some financial exposure to CenturyLink (CTL) if the lawsuit alleging that the company overcharged customers is found to have merit, but he believes the impact is likely not that material. As support for that view, Flannery points to the precedent set by telecom operators' "cramming" lawsuits, settlements of which are "usually...not that material." He keeps an Overweight rating and $27 price target on CenturyLink, adding that the potential triggering of a "MAC" clause in its deal with Level 3 (LVLT) would "seem to be a pretty high bar" and appears unlikely.
05/15/17
RAJA
05/15/17
DOWNGRADE
RAJA
Underperform
CenturyLink downgraded to Underperform from Market Perform at Raymond James
Raymond James analyst Frank Louthan downgraded Level 3 (LVLT) and CenturyLink (CTL) to Underperform saying both companies are experiencing negative trends ahead of their combination which are unlikely to improve over the next few quarters. Louthan also expects additional sales disruption from the integration that will limit material stock price appreciation.
03/29/17
MSCO
03/29/17
INITIATION
Target $27
MSCO
Overweight
CenturyLink resumed with an Overweight at Morgan Stanley
Morgan Stanley analyst Simon Flannery resumed coverage on CenturyLink with an Overweight and a $27 price target.
05/04/17
COWN
05/04/17
NO CHANGE
Target $25
COWN
Market Perform
CenturyLink set up for guidance reduction, says Cowen
Cowen analyst Gregory Williams said CenturyLink posted mixed Q1 results with weakness essentially across the board. The company also announced weak Q2 guidance, which he believes sets the company up for downward guidance revisions. Williams maintained his Market Perform rating and lowered his price target to $25 from $27 on CenturyLink shares.
CCOI Cogent
$43.20

-0.65 (-1.48%)

05/02/17
COWN
05/02/17
DOWNGRADE
COWN
Market Perform
Cogent downgraded to Market Perform on valuation at Cowen
Cowen analyst Colby Synesael downgraded Cogent to Market Perform from Outperform citing valuation and maintained a $46 price target. The analyst said risk/reward appears balanced and sees increased risks developing regarding net neutrality.
03/24/17
DBAB
03/24/17
INITIATION
Target $48
DBAB
Buy
Cogent initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Matthew Niknam started Cogent Communications with a Buy rating and $48 price target. The analyst expects double-digit growth, accelerating profitability and a "material ramp" in shareholder returns.
05/05/17
RHCO
05/05/17
NO CHANGE
RHCO
Cogent decline creates buying opportunity, says SunTrust
SunTrust analyst Greg Miller says that the decline of Cogent's stock following "solid" results and its comments about weaker sequential volume growth creates a buying opportunity. The analyst expects the company's volume growth to "ultimately recover," enabling revenue to increase at least 10% and margins to rise next year.
03/24/17
03/24/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. American Express (AXP) initiated with a Neutral at Tigress Financial. 2. Zosano Pharma (ZSAN) initiated with an Overweight at Piper Jaffray. 3. SkyWest (SKYW) initiated with an In-Line at Imperial Capital. 4. Statoil (STO) initiated with an Underperform at Macquarie. 5. Cogent (CCOI) initiated with a Buy at Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
COR CoreSite Realty
$107.95

-0.07 (-0.06%)

05/17/17
WELS
05/17/17
INITIATION
Target $94
WELS
Market Perform
CoreSite Realty initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Eric Luebch started CoreSite Realty with a Market Perform rating and $94 price target.
05/17/17
05/17/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. CoreSite Realty (COR) initiated with a Market Perform at Wells Fargo. 2. Acceleron (XLRN) initiated with a Sell at Goldman Sachs. 3. Cardinal Health (CAH) initiated with a Hold at Jefferies. 4. Concho Resources (CXO) assumed with an Overweight at Piper Jaffray. 5. Triangle Capital (TCAP) initiated with a Buy at Wunderlich. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/03/17
SBSH
05/03/17
DOWNGRADE
Target $103
SBSH
Neutral
CoreSite Realty downgraded to Neutral from Buy at Citi
Citi analyst Michael Rollins downgraded CoreSite Realty to Neutral saying the current valuation limits upside potential. The analyst raised his price target for the shares to $103 from $98 following the Q1 results.
06/30/17
FBCO
06/30/17
INITIATION
Target $103
FBCO
Neutral
CoreSite Realty initiated with a Neutral at Credit Suisse
Credit Suisse analyst Sami Badri started coverage of the Data Center REITS, initiating CoreSite Realty with a Neutral rating and $103 price target, saying that upside is already priced in at current levels.

TODAY'S FREE FLY STORIES

AMGN

Amgen

$184.86

-1.14 (-0.61%)

12:23
06/23/18
06/23
12:23
06/23/18
12:23
Hot Stocks
Amgen's Repatha 'significantly reduced' LDL-C, non-HDL-C in Type 2 diabetes »

Amgen announced new data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

12:18
06/23/18
06/23
12:18
06/23/18
12:18
Hot Stocks
Eli Lilly's Trulicity shows promise in delivering efficacy in type 2 diabetes »

Two investigational doses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

IRWD

Ironwood

$19.35

0.74 (3.98%)

12:14
06/23/18
06/23
12:14
06/23/18
12:14
Hot Stocks
Ironwood announced Praliciguat phase IIa study data »

Ironwood Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

12:07
06/23/18
06/23
12:07
06/23/18
12:07
Hot Stocks
Array BioPharma announces updated results from Phase 3 BEACON CRC trial »

Array BioPharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 30

    Jun

  • 30

    Jun

DDAIF

Daimler AG

$0.00

(0.00%)

, BMWYY

BMW

$0.00

(0.00%)

11:42
06/23/18
06/23
11:42
06/23/18
11:42
Periodicals
EU to respond to any U.S. auto tariffs, Reuters reports »

The EU will respond to…

DDAIF

Daimler AG

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$67.60

-0.2 (-0.29%)

, GE

General Electric

$13.05

0.29 (2.27%)

11:27
06/23/18
06/23
11:27
06/23/18
11:27
Periodicals
Adding Walgreens to Dow may be wrong move, Barron's says »

The guardians of Dow…

WBA

Walgreens Boots Alliance

$67.60

-0.2 (-0.29%)

GE

General Electric

$13.05

0.29 (2.27%)

FB

Facebook

$201.39

-0.07 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

JPM

JPMorgan

$105.73

-1.79 (-1.66%)

, C

Citi

$67.20

-0.43 (-0.64%)

11:04
06/23/18
06/23
11:04
06/23/18
11:04
Periodicals
Banks to get green light to increase dividends, share repurchases, Barron's says »

Big banks are expected to…

JPM

JPMorgan

$105.73

-1.79 (-1.66%)

C

Citi

$67.20

-0.43 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 26

    Jul

  • 12

    Oct

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

  • 15

    Oct

MD

Mednax

$44.99

-0.11 (-0.24%)

10:59
06/23/18
06/23
10:59
06/23/18
10:59
Periodicals
Mednax shares may be at risk amid hospital fights, Barron's says »

After peaking in 2015,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

10:25
06/23/18
06/23
10:25
06/23/18
10:25
Conference/Events
Array BioPharma to hold a conference call »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 30

    Jun

  • 30

    Jun

TWTR

Twitter

$45.90

0.68 (1.50%)

, FOXA

21st Century Fox

$48.59

0.25 (0.52%)

10:21
06/23/18
06/23
10:21
06/23/18
10:21
Periodicals
Biggest winner of World Cup could be Twitter, Barron's says »

Twitter's (TWTR)…

TWTR

Twitter

$45.90

0.68 (1.50%)

FOXA

21st Century Fox

$48.59

0.25 (0.52%)

AMZN

Amazon.com

$1,715.07

-15.13 (-0.87%)

FB

Facebook

$201.39

-0.07 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

AAPL

Apple

$184.85

-0.63 (-0.34%)

, DDAIF

Daimler AG

$0.00

(0.00%)

10:10
06/23/18
06/23
10:10
06/23/18
10:10
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$184.85

-0.63 (-0.34%)

DDAIF

Daimler AG

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

STMP

Stamps.com

$252.60

0.65 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

A

Agilent

$62.79

-0.24 (-0.38%)

, ABT

Abbott

$61.93

0.19 (0.31%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
American Diabetes Association to hold a conference »

78th Scientific Sessions…

A

Agilent

$62.79

-0.24 (-0.38%)

ABT

Abbott

$61.93

0.19 (0.31%)

AKCA

Akcea Therapeutics

$26.24

0.4 (1.55%)

AMGN

Amgen

$184.86

-1.14 (-0.61%)

AZN

AstraZeneca

$35.06

-0.095 (-0.27%)

BAYRY

Bayer

$0.00

(0.00%)

CL

Colgate-Palmolive

$64.63

1.15 (1.81%)

DXCM

DexCom

$99.52

-0.2 (-0.20%)

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

IRWD

Ironwood

$19.35

0.74 (3.98%)

JNJ

Johnson & Johnson

$122.81

1.36 (1.12%)

MDT

Medtronic

$86.80

0.51 (0.59%)

MNKD

MannKind

$1.98

0.02 (1.02%)

WAKE

Wake Forest Bancshares Inc.

$0.00

(0.00%)

VLRX

Valeritas

$1.39

0.035 (2.58%)

TNDM

TNDM

SNY

Sanofi

$39.98

0.96 (2.46%)

SIEGY

Siemens

$0.00

(0.00%)

SENS

Senseonics

$4.76

-0.2 (-4.03%)

REGN

Regeneron

$331.82

2.81 (0.85%)

PODD

Insulet

$97.37

0.5697 (0.59%)

NVO

Novo Nordisk

$46.84

0.435 (0.94%)

MRK

Merck

$61.46

0.295 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 28

    Jun

  • 02

    Jul

  • 06

    Jul

  • 12

    Jul

  • 17

    Jul

  • 18

    Jul

  • 11

    Aug

  • 27

    Aug

  • 30

    Aug

  • 10

    Sep

  • 06

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 28

    Jan

  • 22

    Mar

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
Array BioPharma to hold a conference call »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 30

    Jun

  • 30

    Jun

ICE

IntercontinentalExchange

$74.81

-0.11 (-0.15%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
IntercontinentalExchange management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

AMGN

Amgen

$184.86

-1.14 (-0.61%)

, ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO World Congress on…

AMGN

Amgen

$184.86

-1.14 (-0.61%)

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

BAYRY

Bayer

$0.00

(0.00%)

HALO

Halozyme

$18.07

-0.52 (-2.80%)

INCY

Incyte

$74.02

1.55 (2.14%)

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

MRK

Merck

$61.46

0.295 (0.48%)

SHPG

Shire

$161.73

-0.7 (-0.43%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$39.98

0.96 (2.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 28

    Jun

  • 30

    Jun

  • 30

    Jun

  • 10

    Sep

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 21

    Dec

  • 28

    Jan

  • 22

    Mar

NWN

Northwest Natural Gas

$62.63

0.075 (0.12%)

, PCG

PG&E

$42.98

2.44 (6.02%)

18:17
06/22/18
06/22
18:17
06/22/18
18:17
Hot Stocks
Northwest Natural to sell Gill Ranch Storage to SENSA Holdings »

NW Natural (NWN)…

NWN

Northwest Natural Gas

$62.63

0.075 (0.12%)

PCG

PG&E

$42.98

2.44 (6.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

ORLY

O'Reilly Automotive

$285.90

-1.18 (-0.41%)

18:03
06/22/18
06/22
18:03
06/22/18
18:03
Hot Stocks
O'Reilly Automotive's O'Reilly sells 19,250 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJI

South Jersey Industries

$33.15

0.02 (0.06%)

17:46
06/22/18
06/22
17:46
06/22/18
17:46
Hot Stocks
South Jersey Industries announces approval of Elizabethtown Gas purchase »

South Jersey Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAAS

AquaVenture

$15.36

0.12 (0.79%)

17:27
06/22/18
06/22
17:27
06/22/18
17:27
Hot Stocks
AquaVenture extends long-stop date for Ghana plant acquisition to September 30 »

AquaVenture announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

17:22
06/22/18
06/22
17:22
06/22/18
17:22
Periodicals
Nissan chooses Thailand for hybrid's first export market, Nikkei reports »

Nissan has planned to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROV

Trovagene

$0.81

-0.0068 (-0.83%)

17:22
06/22/18
06/22
17:22
06/22/18
17:22
Hot Stocks
Trovagene CEO William Welch resigns, Dr. Thomas Adams named interim CEO »

Trovagene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$3.26

0.005 (0.15%)

17:19
06/22/18
06/22
17:19
06/22/18
17:19
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACM

Aecom

$33.49

-0.15 (-0.45%)

17:19
06/22/18
06/22
17:19
06/22/18
17:19
Hot Stocks
Aecom to compete for $148.5M U.S. Army contract »

AECOM-Baker JV, Bryan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

17:17
06/22/18
06/22
17:17
06/22/18
17:17
Hot Stocks
Lockheed Martin awarded $175.3M U.S. Navy contract modification »

Lockheed Martin is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

17:16
06/22/18
06/22
17:16
06/22/18
17:16
Hot Stocks
Lockheed Martin awarded $1.12B U.S. Air Force contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.